A gene-editing technology that is being explored by scientists worldwide as a way of removing and replacing gene defects might inadvertently increase cancer risk in cells, scientists warned on Monday

Quick Read

A new tool for understanding brain diseases. Marius Wernig writes, “Our team at Stanford University has just figured out the recipe for converting blood cells from adults directly into nerve cells, or neurons. You may be wondering why anyone would want to convert blood into brain cells.”

Quick Read

Discussions concerning to the ethical issues related to stem cells have been ongoing for many years, but a special section in the latest issue of Perspectives in Biology and Medicine takes a deep look at some of the newest and most complex issues – including the direct global sales of services and untested and unproven products marketed as stem cells. Guest edited by Tamra Lysaght and Jeremy Sugarman

Quick Read

The Food and Drug Administration’s crusade against irresponsible stem cell clinics is heating up. On Wednesday, the agency announced it was seeking permanent injunctions against two of the most prominent clinics in the US. The injunctions, if successful, would bar the clinics and specific doctors there from performing unapproved stem cell therapies

Quick Read

They’re the tech-age version of donor jars at the diner: crowdfunding websites that aim to link ailing people with strangers willing to help pay for medical treatment. But new research suggests duped patients sometimes crowdfund to pay for bogus stem cell treatments.

Quick Read

Dutch scientists have built “synthetic” embryos in their laboratory using mouse cells other than sperm and eggs. The stem cell breakthrough, described in Nature journal, is not for cloning people or animals, but about understanding why many pregnancies fail at an early stage – implantation

Quick Read

The Harvard Embryonic Stem Cell Research Oversight (the “ESCRO”) Committee, an ethics oversight committee charged with reviewing research protocols involving human embryos, human embryonic stem cells, and certain activities with non-embryonic human pluripotent stem cells, recently issued a report exploring the ethical issues related to the creation of synthetic human embryos

Quick Read

(Video, watch now) In this panel discussion held at NYSCF headquarters, members of the John Hopkins Berman Institute of Bioethics, patient advocates, and scientists engaged in a discussion exploring the ethics and decision-making of stem cell treatments around the world. Featuring our Jeffrey Kahn, Francesco Clark, David Carmel and Susan Solomon

Quick Read